The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers.

J Subst Abuse Treat. 1984;1(4):237-47. Unique Identifier : AIDSLINE MED/85264931
Marmor M; Des Jarlais DC; Friedman SR; Lyden M; el-Sadr W

Abstract: Intravenous (IV) users of illicit drugs have accounted for 17% of AIDS cases seen in the United States. Previous research has shown that more than half of IV drug abusers entering a drug detoxification program in New York City had serologic evidence of exposure to the virus believed to cause AIDS. Spread of AIDS among drug abusers presumably occurs by transmission of the virus via shared needles, works, or drug-containing solutions. Secondary spread of AIDS from IV drug abusers to others may occur by venereal transmission or by perinatal transmission to infants. In this article, relevant characteristics of the AIDS epidemic are presented to assist the staff of drug treatment programs in their work with IV drug abusers. Suggestions regarding the education of drug treatment personnel and the dissemination of information about AIDS to drug abusers and their families are offered. Fact sheets on AIDS for drug treatment and prison staff, and for drug abusers with and without the disease are presented. Finally, possible approaches to the prevention of AIDS in drug users are discussed.
Keywords: Acquired Immunodeficiency Syndrome/BLOOD/DIAGNOSIS/EPIDEMIOLOGY/ ETIOLOGY/PREVENTION & CONTROL/*TRANSMISSION Female Health Education Human HTLV-BLV Viruses Infant Injections, Intravenous/ADVERSE EFFECTS Male New York City Prisons Rehabilitation Centers Substance Abuse/*COMPLICATIONS/THERAPY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/blood/diagnosis/epidemiology/etiology/prevention&control/KWDtransmissionfemalehealtheducationhumanhtlv-blvvirusesinfantinjections,intravenous/adverseeffectsmalenewyorkcityprisonsrehabilitationcenterssubstanceabuse/KWDcomplications/therapysupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticle
851130
M85B0197

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .